Informations techniques
Exploitant
LUPIN EUROPE GmbH
Présentation
NAMUSCLA 167 mg, gélule
B/30 (CIP : 34009 301 721 2 4)
B/50 (CIP : 34009 301 721 3 1)
B/100 (CIP : 34009 301 721 4 8)
B/200 (CIP : 34009 550 625 8 5)
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
3wXD4UcvMrvAWXbE
Français